Towards a Reduced <i>In Silico</i> Model Predicting Biochemical Recurrence After Radiotherapy in Prostate Cancer

نویسندگان

چکیده

Objective: Purposes of this work were i) to develop an in silico model tumor response radiotherapy, ii) perform exhaustive sensitivity analysis order iii) propose a simplified version and iv) predict biochemical recurrence with both the comprehensive reduced model. Methods: A multiscale computational radiotherapy was developed. It integrated following radiobiological mechanisms: oxygenation, including hypoxic death; division cells; VEGF diffusion driving angiogenesis; healthy cells oxygen-dependent irradiation, considering, cycle arrest mitotic catastrophe. thorough using Morris screening method performed on 21 prostate tissues. Tumor control probability (TCP) curves 15 versions compared. Logistic regression after 76 localized cancer patients output models. Results: No significant difference found between TCP which only considered their irradiation. Biochemical predictions models improved those made from pre-treatment imaging parameters (AUC = 0.81 ± 0.02 0.82 vs. 0.75 0.03, respectively). Conclusion: able obtained. Significance: This may be used future optimize personalized fractionation schedules.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Predicting Prostate Cancer Recurrence After Radical Prostatectomy.

BACKGROUND Prostate cancer prognosis is variable, and management decisions involve balancing patients' risks of recurrence and recurrence-free death. Moreover, the roles of body mass index (BMI) and race in risk of recurrence are controversial [1,2]. To address these issues, we developed and cross-validated RAPS (Risks After Prostate Surgery), a personal prediction model for biochemical recurre...

متن کامل

Association between prostate specific antigen change over time and prostate cancer recurrence risk: a joint model

Background: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the joint modeling. Methods: This historical cohort study was performed on 422 prostate cancer patients. Inclusion criteria included: patients with loc...

متن کامل

[Prostate cancer recurrence after radical prostatectomy and salvage radiotherapy].

OBJECTIVE To evaluate the efficacy of the radiotherapy to prostatic bed in patients with biochemical recurrence for prostate cancer after radical prostatectomy. MATERIAL AND METHODS We analyse the results of 292 patients underwent radical prostatectomy for localized prostate cancer T1-T2 between January 1992 and June 2003, with an average folow-up of 36 months (range 6 months to 12 years). We...

متن کامل

Aureon Prostate PxTM Predicting Prostate Cancer Recurrence

Aureon Laboratories is applying its integrative Systems Pathology platform to develop predictive clinical tests for prostate cancer patients. The initial offering is Prostate Px™, a unique prognostic test designed to provide patients and their physicians with more information as they make decisions about treatment options. Prostate Px is able to stratify patients as high or low risk for disease...

متن کامل

Early stage prostate cancer: biochemical recurrence after treatment.

OBJECTIVES To identify retrospectively through chart analysis the biochemical recurrence frequency of localized prostate cancer at diagnosis of patients submitted to surgery or radiotherapy; to correlate diagnostic characteristics associated with higher risk of biochemical recurrence. MATERIALS AND METHODS Retrospective analysis of 483 patients treated in a single center, from March 2000 to D...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: IEEE Transactions on Biomedical Engineering

سال: 2021

ISSN: ['0018-9294', '1558-2531']

DOI: https://doi.org/10.1109/tbme.2021.3052345